About Breakthrough Symposium
The inaugural Breakthrough Symposium was held in 2018 to bring together individuals and organizations that lead the biotechnology community. Participants shared the latest advancements in gene and cell therapy, gene editing and more, while networking with thought leaders who will spark tomorrow’s breakthroughs and celebrate the latest developments in bioscience.
Breakthrough Symposium is hosted by Aldevron in its corporate home of Fargo, North Dakota. Aldevron is a leading supplier of plasmid DNA, proteins, enzymes, antibodies, and other biologicals that enable groundbreaking achievement in life science.
Below are a few of the topics from our accomplished roster of speakers at the 2018 event, with recordings as available:
Discuss manufacturing considerations in cell therapy development
with Anne Kantardjieff, Director of Plasmids and Small Molecules Manufacturing at bluebird bio.
Discover the potential for gene editing and CRISPR/Cas9
from Matthew Porteus, Associate Professor, Department of Pediatrics, the Institute of Stem Cell Biology and Regenerative Medicine at Stanford University and Kris Saha, Department of Biomedical Engineering, University of Wisconsin-Madison
Collaborate on the latest gene therapy manufacturing developments
with Andrew Moreo, Operations Manager, GMP and Viral Vector Core Facilities, Nationwide Children’s Hospital and Anne Kantardjieff, Director of Plasmids and Small Molecules Manufacturing, bluebird bio
Hear about the progress in AAV gene therapy
from Luk H. Vandenberghe, Assistant Professor at Harvard Medical School and Mark Osborn, Assistant Professor, University of Minnesota